Australian & New Zealand Childhood Hematology & Oncology Group

Academic/Hospital

Also known as: Australian & New Zealand Childhood Hematology & Oncology Group (Co-Sponsor Australia/NZ) | Australian & New Zealand Children's Haematology/Oncology Group

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Sep 1, 2017

Last known activity

Jul 10, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (6 distinct, 3 trials)

Phase 2 (6 own, 0 via acquisition)

irinotecan
gdc-0084
panobinostat
temozolomide
bortezomib
pimasertib

Indications

Studied for

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Recent trials (3)

NCT06208657Lead sponsorPhase 1/Phase 2Jul 10, 2024
NCT04897880Lead sponsorPhase 2Jan 9, 2019
NCT03590171CollaboratorPhase 2Sep 1, 2017

Details

Last known activity: Jul 10, 2024